Bosulif 50 MG Oral Capsule

RxCUI: 2672328
RxNorm name: Bosulif 50 MG Oral Capsule
Display name: Bosulif 50 MG Oral Capsule
Full name: Bosulif 50 MG Oral Capsule
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:15

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
BOSULIF	BOSUTINIB	Pfizer Laboratories Div Pfizer Inc	adc84ad5-a04d-4fee-9ba8-91f7abd928e3	2026-03-10	Warnings, Adverse reactions	Exact identifier rxcui: 2672328

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
adc84ad5-a04d-4fee-9ba8-91f7abd928e3	Bosulif 50 MG Oral Capsule [PSN] · bosutinib 50 MG Oral Capsule [Bosulif] [SBD] · Bosulif 50 MG Oral Capsule [SY]	3	32	These highlights do not include all the information needed to use BOSULIF safely and effectively. See full prescribing information for BOSULIF. BOSULIF ® (bosutinib) tablets, for oral use BOSULIF ® (bosutinib) capsules, for oral use Initial U.S. Approval: 2012	20260310